<bill session="103" type="h" number="1588" updated="2010-04-19T03:19:23-04:00">
	<state datetime="1993-04-01">REFERRED</state>
	<status><introduced datetime="1993-04-01"/></status>

	<introduced datetime="1993-04-01"/>
	<titles>
		<title type="official" as="introduced">To amend the Internal Revenue Code of 1986 to impose a windfall profit tax on certain drugs for rare diseases or conditions if they become excessively profitable, and for other purposes.</title>
	</titles>
	<sponsor id="400387"/>
	<cosponsors>

	</cosponsors>
	<actions>
		<action datetime="1993-04-01"><text>Sponsor introductory remarks on measure. (CR H1851-1852)</text></action>
		<action datetime="1993-04-01"><text>Referred to the House Committee on Ways and Means.</text></action>
		<action datetime="1993-04-05"><text>Sponsor introductory remarks on measure. (CR H1883-1884)</text></action>
	</actions>
	<committees>
		<committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee" />
	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Income tax"/>
		<term name="Drug industry"/>
		<term name="Excess profits tax"/>
		<term name="Medical care"/>
		<term name="Orphan drugs"/>
		<term name="Pharmaceutical research"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	4/1/1993--Introduced.
Amends the Internal Revenue Code to impose a windfall profits tax (after recovery of the total investment in drug development) on the profits from orphan drugs for rare diseases or conditions.

	</summary>
</bill>
